Flagship merger ‘effectively scrapped’ after ‘wasting millions’

The leader of a flagship ‘hub and spoke’ pathology merger has criticised regulators after the project was effectively dropped due to delays in receiving £31m of capital that was allocated to the scheme in 2018.